fbpx
February 17, 2023

US Food Benefits to Poor to Shrink as Pandemic Provisions End US Food Benefits to Poor to Shrink as Pandemic Provisions End

(Reuters) – Low-income Americans will soon receive less in food assistance or completely lose their eligibility for the benefits, as the federal government ends policies adopted […]
February 17, 2023

Inside the Big Business of Clogged Arteries Inside the Big Business of Clogged Arteries

On June 14, 2017, just before noon, a doctor made an incision near a patient’s groin. Kari Kirk, a representative for the world’s largest medical device […]
February 17, 2023

China Declares ‘Decisive Victory’ Over COVID-19 China Declares ‘Decisive Victory’ Over COVID-19

BEIJING (Reuters) – China’s top leaders declared a “decisive victory” over COVID-19, claiming the world’s lowest fatality rate, although experts have questioned Beijing’s data as the […]
February 17, 2023

How to Recognize and Treat Hidden Inflammation How to Recognize and Treat Hidden Inflammation

Immunoglobulin G4 (IgG4) fights viruses and bacteria. However, sometimes it targets the body itself. “This then leads to inflammation, the healing of which the body is unable […]
February 17, 2023

COVID Infection Provides Immunity Equal to Vaccination: Study COVID Infection Provides Immunity Equal to Vaccination: Study

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The natural immunity provided by a COVID infection protects a person against […]
February 17, 2023

Talazoparib Add-On Improves Outcomes in Metastatic Prostate Cancer Talazoparib Add-On Improves Outcomes in Metastatic Prostate Cancer

SAN FRANCISCO — Adding the PARP-inhibitor talazoparib (Talzenna, Pfizer) to treatment with the androgen pathway inhibitor enzalutamide (Xtandi, Astellas, Pfizer) significantly improved progression-free survival (PFS) in […]
February 17, 2023

Similar Survival Observed After Transplantation vs Chemo in AML Similar Survival Observed After Transplantation vs Chemo in AML

Patients with intermediate-risk acute myeloid leukemia (AML) who underwent allogeneic hematopoietic cell transplantation (HCT) after their first complete remission showed improvements in disease-free survival but had […]
February 17, 2023

New Cancer Screen, Same Issues: Physicians Confront Galleri Test New Cancer Screen, Same Issues: Physicians Confront Galleri Test

In January 2022, Anthony Arenz, a 51-year-old living in Mesa, Arizona, breathed a small sigh of relief. The Galleri blood test, which screens for 50 types […]
February 17, 2023

Judge Weighs Key Evidence Ahead of First Zantac Cancer Trial Judge Weighs Key Evidence Ahead of First Zantac Cancer Trial

(Reuters) – Lawyers for a man who alleges he developed bladder cancer after taking GSK Plc’s heartburn drug Zantac urged a California judge on Thursday to […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0